NeoGenomics
Logotype for NeoGenomics Inc

NeoGenomics (NEO) investor relations material

NeoGenomics 44th Annual J.P. Morgan Healthcare Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for NeoGenomics Inc
44th Annual J.P. Morgan Healthcare Conference summary14 Jan, 2026

Strategic vision and market positioning

  • Focused exclusively on oncology diagnostics, with a strong presence in community settings where 80% of cancer patients are treated.

  • Leadership in hematology leveraged to expand into solid tumor therapy selection and MRD markets, holding over 25% hematology market share.

  • Three strategic pillars: expand from HEME into new markets, evolve offerings for community oncologists, and make targeted investments for growth and margin expansion.

  • Breadth of test menu and community oncology focus differentiates from larger labs and specialty diagnostics.

  • Mission centers on improving patient care and becoming the leading provider of comprehensive cancer testing and solutions.

Product innovation and launches

  • Comprehensive test menu spans diagnosis to MRD, with new launches like PanTracer tissue and PanTracer liquid biopsy.

  • RaDaR-ST MRD test launching in Q1, targeting a $20B+ market, with two indications approved and two more submitted for reimbursement.

  • Five new products launched in 2023 are projected to contribute ~24% of 2025 clinical revenue.

  • PanTracer tissue volumes doubled year-over-year, and liquid biopsy introduced in response to customer demand.

  • Favorable reimbursement decisions and multiple patents support new product launches.

Community oncology and customer engagement

  • Over 4,000 ordering accounts and 15% year-over-year growth in physicians ordering five or more tests.

  • High Net Promoter Score (78) reflects strong physician satisfaction, driven by ease of ordering, report simplicity, and comprehensive test menu.

  • Sales team expansion accelerates penetration among community oncologists, with increased ordering and headcount from 2023 to 2025.

  • Targeted investments aim to drive top-line growth and margin expansion in the community setting.

  • Community oncology is critical for health equity, cost-effectiveness, and personalized care.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next NeoGenomics earnings date

Logotype for NeoGenomics Inc
Q4 202517 Feb, 2026
NeoGenomics
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next NeoGenomics earnings date

Logotype for NeoGenomics Inc
Q4 202517 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

NeoGenomics Inc provides cancer-focused genetic testing services, including clinical and research laboratory diagnostics. The company offers molecular, cytogenetic, and flow cytometry testing to pathologists, oncologists, and pharmaceutical companies. It supports precision medicine and oncology drug development. The company is headquartered in Fort Myers, Florida, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage